Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 437.40
-4.00 (-0.91%)
Aug 29, 2025, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 31.07 billion as of August 29, 2025. Its market cap has decreased by -49.86% in one year.
Market Cap
31.07B
Enterprise Value
14.89B
Revenue
9.11B
Ranking
n/a
PE Ratio
4.71
Stock Price
437.40
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 31.07B, an increase of 2,110.00%. That is a compound annual growth rate of 23.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 31.07B | -38.54% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | 8.77B | 3.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,559.42B |
| Coloplast | 137.44B |
| Genmab | 97.03B |
| Demant | 51.46B |
| ALK-Abelló | 44.64B |
| H. Lundbeck | 37.41B |
| Ambu A/S | 26.16B |
| Bavarian Nordic | 18.61B |